Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse

Identifieur interne : 003473 ( Main/Exploration ); précédent : 003472; suivant : 003474

Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse

Auteurs : John M. Young [États-Unis] ; Patrick J. Maloney [États-Unis] ; Shizu N. Jubb [États-Unis] ; Jeffrey S. Clark [États-Unis]

Source :

RBID : ISTEX:7B17991467E77F02DA660C0C5F027CFD5E9645B3

English descriptors

Abstract

Abstract: Although the platelets the mouse are refractory to the direct effects of platelet-activating-factor (PAF0, tail vein injection of 10–150 μg/kg PAF produces lethal anaphylatic shook. Sensitivity varies with strain and source: Swiss Webster mice show a range of sensitivity and DBA/2 (complement C5-deficient) mice are very resistant. At lethal doses within 15–45 min. Dexamethasone administered at least 1.5 hr prior consistently protects, whereas the cyclooxygenase inhibitors do not. Antihistamines, adrenergic antagonists, and methysergide have no effect, but cyproheptidine is partially protective at near lethal doses. Calcium entry blockers and calcium chelators, tetracyline and chlortetracycline are partially protective at very high doses consistent with non-specific effects on calcium dependent processes. The arachidonic acid lipoxygenase inhibitors BW755c, phenidone, nordihydroguai aretic acid and diphenyl disulfide provide nearly complete protection after oral administration of 50–200 mg/kg. Phosphodiesterase inhibitors and dapsone are also effectively orally. The luekotriene antagonist FPL55712 administered intraperitoneally (10 mg/kg) 5 min. prior to PAF challenge provides almost complete protection. PAF-induced mortality in the mouse represents a small animal model of systematic anaphylaxis particularly useful for the systematic testing of arachidonic acid lipoxygenase inhibitors and leukotriene antagonists.

Url:
DOI: 10.1016/0090-6980(85)90018-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse</title>
<author>
<name sortKey="Young, John M" sort="Young, John M" uniqKey="Young J" first="John M." last="Young">John M. Young</name>
</author>
<author>
<name sortKey="Maloney, Patrick J" sort="Maloney, Patrick J" uniqKey="Maloney P" first="Patrick J." last="Maloney">Patrick J. Maloney</name>
</author>
<author>
<name sortKey="Jubb, Shizu N" sort="Jubb, Shizu N" uniqKey="Jubb S" first="Shizu N." last="Jubb">Shizu N. Jubb</name>
</author>
<author>
<name sortKey="Clark, Jeffrey S" sort="Clark, Jeffrey S" uniqKey="Clark J" first="Jeffrey S." last="Clark">Jeffrey S. Clark</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7B17991467E77F02DA660C0C5F027CFD5E9645B3</idno>
<date when="1985" year="1985">1985</date>
<idno type="doi">10.1016/0090-6980(85)90018-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-LN1C3140-M/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000158</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000158</idno>
<idno type="wicri:Area/Istex/Curation">000158</idno>
<idno type="wicri:Area/Istex/Checkpoint">002231</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002231</idno>
<idno type="wicri:doubleKey">0090-6980:1985:Young J:pharmacological:investigation:of</idno>
<idno type="wicri:Area/Main/Merge">003547</idno>
<idno type="wicri:Area/Main/Curation">003473</idno>
<idno type="wicri:Area/Main/Exploration">003473</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse</title>
<author>
<name sortKey="Young, John M" sort="Young, John M" uniqKey="Young J" first="John M." last="Young">John M. Young</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Bioassay, Institute of Biological Sciences, Syntex Research, 3401 Hillview Avenue, Palo Alto, CA 94304</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Maloney, Patrick J" sort="Maloney, Patrick J" uniqKey="Maloney P" first="Patrick J." last="Maloney">Patrick J. Maloney</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Bioassay, Institute of Biological Sciences, Syntex Research, 3401 Hillview Avenue, Palo Alto, CA 94304</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jubb, Shizu N" sort="Jubb, Shizu N" uniqKey="Jubb S" first="Shizu N." last="Jubb">Shizu N. Jubb</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Bioassay, Institute of Biological Sciences, Syntex Research, 3401 Hillview Avenue, Palo Alto, CA 94304</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Clark, Jeffrey S" sort="Clark, Jeffrey S" uniqKey="Clark J" first="Jeffrey S." last="Clark">Jeffrey S. Clark</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Bioassay, Institute of Biological Sciences, Syntex Research, 3401 Hillview Avenue, Palo Alto, CA 94304</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Prostaglandins</title>
<title level="j" type="abbrev">PROOLD</title>
<idno type="ISSN">0090-6980</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1985">1985</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="545">545</biblScope>
<biblScope unit="page" to="551">551</biblScope>
</imprint>
<idno type="ISSN">0090-6980</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0090-6980</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Allergy</term>
<term>Anaphylaxis</term>
<term>Antagonist</term>
<term>Arachidonic</term>
<term>Blocker</term>
<term>Cyclooxygenase</term>
<term>Dapsone</term>
<term>Diphenyldisulfide</term>
<term>Dos</term>
<term>Hilltop</term>
<term>Iipoxygenase</term>
<term>Inhibitor</term>
<term>Leukocyte</term>
<term>Leukotriene</term>
<term>Lipoxygenase</term>
<term>Mediator</term>
<term>Mouse</term>
<term>October</term>
<term>Pathway</term>
<term>Pharmac</term>
<term>Pharmacologic</term>
<term>Phenidone</term>
<term>Platelet</term>
<term>Prostaglandin</term>
<term>Prostaglandins table</term>
<term>Swiss webster</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Although the platelets the mouse are refractory to the direct effects of platelet-activating-factor (PAF0, tail vein injection of 10–150 μg/kg PAF produces lethal anaphylatic shook. Sensitivity varies with strain and source: Swiss Webster mice show a range of sensitivity and DBA/2 (complement C5-deficient) mice are very resistant. At lethal doses within 15–45 min. Dexamethasone administered at least 1.5 hr prior consistently protects, whereas the cyclooxygenase inhibitors do not. Antihistamines, adrenergic antagonists, and methysergide have no effect, but cyproheptidine is partially protective at near lethal doses. Calcium entry blockers and calcium chelators, tetracyline and chlortetracycline are partially protective at very high doses consistent with non-specific effects on calcium dependent processes. The arachidonic acid lipoxygenase inhibitors BW755c, phenidone, nordihydroguai aretic acid and diphenyl disulfide provide nearly complete protection after oral administration of 50–200 mg/kg. Phosphodiesterase inhibitors and dapsone are also effectively orally. The luekotriene antagonist FPL55712 administered intraperitoneally (10 mg/kg) 5 min. prior to PAF challenge provides almost complete protection. PAF-induced mortality in the mouse represents a small animal model of systematic anaphylaxis particularly useful for the systematic testing of arachidonic acid lipoxygenase inhibitors and leukotriene antagonists.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Young, John M" sort="Young, John M" uniqKey="Young J" first="John M." last="Young">John M. Young</name>
</region>
<name sortKey="Clark, Jeffrey S" sort="Clark, Jeffrey S" uniqKey="Clark J" first="Jeffrey S." last="Clark">Jeffrey S. Clark</name>
<name sortKey="Jubb, Shizu N" sort="Jubb, Shizu N" uniqKey="Jubb S" first="Shizu N." last="Jubb">Shizu N. Jubb</name>
<name sortKey="Maloney, Patrick J" sort="Maloney, Patrick J" uniqKey="Maloney P" first="Patrick J." last="Maloney">Patrick J. Maloney</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003473 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003473 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:7B17991467E77F02DA660C0C5F027CFD5E9645B3
   |texte=   Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021